107 related articles for article (PubMed ID: 22285357)
1. [Thrombosis and breast cancer: incidence, risk factors, physiopathology and treatment].
Médioni J; Guastalla JP; Drouet L
Bull Cancer; 2012 Feb; 99(2):199-210. PubMed ID: 22285357
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
3. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
4. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy.
Levine MN
Thromb Haemost; 1997 Jul; 78(1):133-6. PubMed ID: 9198142
[TBL] [Abstract][Full Text] [Related]
5. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy.
Trappenburg MC; van Schilfgaarde M; Bredewold EO; van Aalderen MC; Spronk HM; Ten Cate H; Leyte A; Terpstra WE
Thromb Res; 2011 Apr; 127(4):363-9. PubMed ID: 21272922
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilic state in breast cancer.
Schmitt M; Kuhn W; Harbeck N; Graeff H
Semin Thromb Hemost; 1999; 25(2):157-66. PubMed ID: 10357083
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathic complications in breast cancer.
Caine GJ; Stonelake PS; Rea D; Lip GY
Cancer; 2003 Oct; 98(8):1578-86. PubMed ID: 14534872
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?
Lechner D; Weltermann A
Semin Thromb Hemost; 2008 Mar; 34(2):199-203. PubMed ID: 18645926
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy in breast cancer and venous thromboembolism.
Mandalà M; Tondini C
Thromb Res; 2012 Oct; 130 Suppl 1():S66-70. PubMed ID: 23026668
[TBL] [Abstract][Full Text] [Related]
10. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis in leukemia: incidence, causes, and practical management.
Guzmán-Uribe P; Vargas-Ruíz ÁG
Curr Oncol Rep; 2015; 17(5):444. PubMed ID: 25712535
[TBL] [Abstract][Full Text] [Related]
12. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy and thrombosis: how to avoid the problem?
Levine MN
Breast; 2007 Dec; 16 Suppl 2():S169-74. PubMed ID: 17720502
[TBL] [Abstract][Full Text] [Related]
14. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated thrombosis.
Sood SL
Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
[TBL] [Abstract][Full Text] [Related]
16. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
Rak J; Klement P; Yu J
Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
[TBL] [Abstract][Full Text] [Related]
18. [Blood coagulation changes and neoplastic pathology].
Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticles and coagulation activation in breast cancer patients.
Toth B; Liebhardt S; Steinig K; Ditsch N; Rank A; Bauerfeind I; Spannagl M; Friese K; Reininger AJ
Thromb Haemost; 2008 Oct; 100(4):663-9. PubMed ID: 18841290
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
